4/7
09:10 am
holx
Blackstone and TPG Complete Acquisition of Hologic
Neutral
Report
Blackstone and TPG Complete Acquisition of Hologic
4/6
08:24 am
holx
Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Go-Private Transaction [Yahoo! Finance]
Low
Report
Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Go-Private Transaction [Yahoo! Finance]
4/6
08:00 am
holx
Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Go-Private Transaction
Low
Report
Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Go-Private Transaction
3/20
09:03 am
holx
Biopsy Devices Market Size Projected to Reach USD 5.08 Billion by 2035; Increasing Incidence of Cancer to Drive Market Growth Globally – SNS Insider [Yahoo! Finance]
Neutral
Report
Biopsy Devices Market Size Projected to Reach USD 5.08 Billion by 2035; Increasing Incidence of Cancer to Drive Market Growth Globally – SNS Insider [Yahoo! Finance]
3/18
01:48 pm
holx
Is Hologic Stock Outperforming the Dow? [Yahoo! Finance]
Low
Report
Is Hologic Stock Outperforming the Dow? [Yahoo! Finance]
3/17
10:11 pm
holx
???????????????????? : ??????? 2035??224????????? ??????9.1%????????????AI????????????? [CNET News]
Low
Report
???????????????????? : ??????? 2035??224????????? ??????9.1%????????????AI????????????? [CNET News]
3/17
08:35 am
holx
1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates [Yahoo! Finance]
Low
Report
1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates [Yahoo! Finance]
3/17
08:00 am
holx
1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates
Low
Report
1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates
2/25
06:23 pm
holx
ImpediMed Appoints Medical Technology Commercialization Expert Erik Anderson to Board of Directors [Yahoo! Finance]
Low
Report
ImpediMed Appoints Medical Technology Commercialization Expert Erik Anderson to Board of Directors [Yahoo! Finance]
2/4
08:15 am
holx
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio
Low
Report
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio
1/30
07:12 pm
holx
HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash [Yahoo! Finance]
Low
Report
HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash [Yahoo! Finance]
1/30
06:06 am
holx
Hologic (NASDAQ:HOLX) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Hologic (NASDAQ:HOLX) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
1/29
04:02 pm
holx
Hologic Announces Financial Results for First Quarter of Fiscal 2026
Low
Report
Hologic Announces Financial Results for First Quarter of Fiscal 2026
1/23
04:36 pm
holx
Analysts consider potential Qiagen deal amid reported strategic review [Yahoo! Finance]
Low
Report
Analysts consider potential Qiagen deal amid reported strategic review [Yahoo! Finance]
1/19
06:16 pm
holx
Hologic, Inc. (HOLX): A Bear Case Theory [Yahoo! Finance]
Low
Report
Hologic, Inc. (HOLX): A Bear Case Theory [Yahoo! Finance]
1/19
10:10 am
holx
Pop-Up Clinics Increasing Access to Cervical Cancer Screenings this Cervical Health Awareness Month [Yahoo! Finance]
Low
Report
Pop-Up Clinics Increasing Access to Cervical Cancer Screenings this Cervical Health Awareness Month [Yahoo! Finance]
1/15
07:00 pm
holx
Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026
Low
Report
Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026
1/13
09:00 am
holx
Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening
Low
Report
Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening
1/12
09:18 am
holx
Hologic (NASDAQ:HOLX) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.
Low
Report
Hologic (NASDAQ:HOLX) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.